Research & Development



  在後世,雲瑯的女朋友還是很多的,就像最後一個女朋友將他一腳踢出門,然後,雲瑯就赤條條無牽掛了。   雲瑯笑道︰“母親莫要惱怒,霍光已經認罪了,也賠錢了,至于狄山,那就是一個窮鬼,除了一身硬骨頭之外,您也指望不上他。”得得撸   阿房宮的地圖拿來了,其實就是一幅畫,雲瑯看了良久,除過知道這座扶荔宮以前叫做采青宮之外,根本就沒有暗道的標識。得得去   丫鬟要點燈,被他驅逐出去了。   現在莊子里有了羊毛產出,就必須把這些羊毛迅速的變成毛氈,然後再售賣出去填補家用。潮吹片   雲瑯拍拍金日的肩頭道︰“你的年紀還小,還不能理解其中意。呵呵呵,別人教徒盼聰明,我願我徒愚且魯,無病無災到公卿!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo